Universitätsklinikum Hamburg-Eppendorf (UKE)

Can contemporary trials in HER2-negative metastatic breast cancer (mBC) detect overall survival (OS) benefit? (2017) Kuemmel S, Jackisch C, Mueller V, Schneeweiss A, Klawitter S, Lux MP Conference contribution TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) Fagerholm R, Khan S, Schmidt MK, Garcia-Closas M, Heikkila P, Saarela J, Beesley J, et al. Journal article Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network (2017) Fremd C, Hack C, Schneeweiss A, Rauch G, Wallwiener D, Brucker SY, Taran FA, et al. Journal article The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial (2017) Jaeger BAS, Neugebauer J, Andergassen U, Melcher C, Schochter F, Mouarrawy D, Ziemendorff G, et al. Journal article Update Breast Cancer 2017 - Implementation of Novel Therapies (2017) Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, et al. Journal article Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database (2017) May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, et al. Journal article Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort (2017) Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, et al. Journal article Genetic variation of PNPLA3 and TM6SF2 associate with hepatocellular carcinoma in patients with alcohol-related cirrhosis (2017) Stickel F, Buch S, Janet F, Rosendahl J, Morgan MY, Nischalke HD, Lammert F, et al. Conference contribution Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014) (2017) Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al. Journal article norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study (2017) Traussnigg S, Schattenberg JM, Demir M, Wiegand J, Geier A, Teuber G, Hofmann WP, et al. Conference contribution